Neuroimaging in amyotrophic lateral sclerosis

被引:36
|
作者
Comi, G [1 ]
Rovaris, M [1 ]
Leocani, L [1 ]
机构
[1] Osped San Raffaele, Inst Sci, Dept Neurophysiol, I-20132 Milan, Italy
关键词
amyotrophic lateral sclerosis; magnetic resonance spectroscopy; magnetization transfer imaging; diffusion weighted imaging;
D O I
10.1046/j.1468-1331.1999.660629.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Amyotrophic lateral sclerosis (ALS) is a chronic degenerative disorder of unknown etiology affecting the motor system. Conventional and non-conventional neuroimaging techniques can provide essential help both to increase the confidence in ALS diagnosis and to assess the disease evolution. Signal abnormalities at the level of the motor cortex and the corticospinal tract on conventional T2-weighted magnetic resonance (MR) images are a potentially useful marker of ALS pathology. However, the prognostic value of these conventional MR abnormalities is still hampered by their low pathological specificity. Non-conventional MR techniques with a higher pathological specificity, such as MR spectroscopy, magnetization transfer imaging and diffusion-weighted imaging, seem to have some potential not only for ALS diagnosis, but also for monitoring disease evolution either naturally or when modified by experimental treatments. Eur J Neurol 6:629-637 (C) 1999 Lippincott Williams & Wilkins.
引用
收藏
页码:629 / 637
页数:9
相关论文
共 50 条
  • [21] Validation of a neuroimaging based diagnostic protocol for Amyotrophic Lateral Sclerosis
    Bede, Peter
    Hardiman, Orla
    NEUROLOGY, 2017, 88
  • [22] Biological and neuroimaging biomarkers for amyotrophic lateral sclerosis: 2013 and beyond
    Blasco, Helene
    Corcia, Philippe
    Gordon, Paul H.
    Pradat, Pierre-Francois
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2013, 3 (05) : 427 - 444
  • [23] Functional Neuroimaging in Amyotrophic Lateral Sclerosis: Analysis of Resting Activity
    Kollewe, K.
    Muente, T. F.
    Samii, A.
    Dengler, R.
    Petri, S.
    Mohammadi, B.
    KLINISCHE NEUROPHYSIOLOGIE, 2009, 40 (04) : 263 - 269
  • [24] Potential of neuroimaging as a biomarker in amyotrophic lateral sclerosis: from structure to metabolism
    Wei Sun
    Si-Han Liu
    Xiao-Jing Wei
    Hui Sun
    Zhen-Wei Ma
    Xue-Fan Yu
    Journal of Neurology, 2024, 271 : 2238 - 2257
  • [25] Potential of neuroimaging as a biomarker in amyotrophic lateral sclerosis: from structure to metabolism
    Sun, Wei
    Liu, Si-Han
    Wei, Xiao-Jing
    Sun, Hui
    Ma, Zhen-Wei
    Yu, Xue-Fan
    JOURNAL OF NEUROLOGY, 2024, 271 (05) : 2238 - 2257
  • [26] Positron emission tomography neuroimaging in amyotrophic lateral sclerosis: what is new?
    Quartuccio, N.
    Van Weehaeghe, D.
    Cistaro, A.
    Jonsson, C.
    Van Laere, K.
    Pagani, M.
    QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 58 (04): : 344 - 354
  • [27] Advanced neuroimaging approaches in amyotrophic lateral sclerosis: refining the clinical diagnosis
    Kassubek, Jan
    Mueller, Hans-Peter
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2020, 20 (03) : 237 - 249
  • [28] Neuroimaging to Investigate Multisystem Involvement and Provide Biomarkers in Amyotrophic Lateral Sclerosis
    Pradat, Pierre-Francois
    El Mendili, Mohamed-Mounir
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [29] The Utilization of 3 Tesla Neuroimaging as a Biomarker for Cognitive Impairment in Amyotrophic Lateral Sclerosis
    Bede, Peter
    Doherty, Colin
    Bokde, Arun
    Ewers, Michael
    Hampel, Harald
    Hardiman, Orla
    NEUROLOGY, 2010, 74 (09) : A217 - A217
  • [30] AMYOTROPHIC LATERAL SCLEROSIS
    BROWNELL, AKW
    ARCHIVES OF NEUROLOGY, 1989, 46 (05) : 480 - 480